Tags

Type your tag names separated by a space and hit enter

Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
Clin Immunol. 2020 08; 217:108496.CI

Authors+Show Affiliations

Department of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, United States of America. Electronic address: eric.yager@acphs.edu.

Pub Type(s)

Letter

Language

eng

PubMed ID

32526272

Citation

Yager, Eric J.. "Antibody-dependent Enhancement and COVID-19: Moving Toward Acquittal." Clinical Immunology (Orlando, Fla.), vol. 217, 2020, p. 108496.
Yager EJ. Antibody-dependent enhancement and COVID-19: Moving toward acquittal. Clin Immunol. 2020;217:108496.
Yager, E. J. (2020). Antibody-dependent enhancement and COVID-19: Moving toward acquittal. Clinical Immunology (Orlando, Fla.), 217, 108496. https://doi.org/10.1016/j.clim.2020.108496
Yager EJ. Antibody-dependent Enhancement and COVID-19: Moving Toward Acquittal. Clin Immunol. 2020;217:108496. PubMed PMID: 32526272.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antibody-dependent enhancement and COVID-19: Moving toward acquittal. A1 - Yager,Eric J, Y1 - 2020/06/08/ PY - 2020/06/04/received PY - 2020/06/07/accepted PY - 2020/6/12/pubmed PY - 2020/7/22/medline PY - 2020/6/12/entrez KW - Antiviral antibodies KW - COVID-19 KW - Coronavirus KW - Vaccines KW - Viral immunity SP - 108496 EP - 108496 JF - Clinical immunology (Orlando, Fla.) JO - Clin Immunol VL - 217 SN - 1521-7035 UR - https://www.unboundmedicine.com/medline/citation/32526272/Antibody_dependent_enhancement_and_COVID_19:_Moving_toward_acquittal_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1521-6616(20)30509-X DB - PRIME DP - Unbound Medicine ER -